Robert D. Schwab

867 total citations · 1 hit paper
9 papers, 200 citations indexed

About

Robert D. Schwab is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Robert D. Schwab has authored 9 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Robert D. Schwab's work include CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Robert D. Schwab is often cited by papers focused on CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Robert D. Schwab collaborates with scholars based in United States. Robert D. Schwab's co-authors include Avery D. Posey, Joseph A. Fraietta, Marcela V. Maus, Stephen Bagley, Adam Smith, Angela N. Viaene, Moumita Dasgupta, MacLean P. Nasrallah, Steven Brem and Ashley R. Carter and has published in prestigious journals such as Cell, Nucleic Acids Research and Circulation.

In The Last Decade

Robert D. Schwab

9 papers receiving 200 citations

Hit Papers

Advances in cancer immunotherapies 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. Schwab United States 4 87 74 62 58 24 9 200
Jane Chuprin United States 4 94 1.1× 61 0.8× 46 0.7× 127 2.2× 23 1.0× 5 244
Yimei Que China 8 37 0.4× 109 1.5× 60 1.0× 73 1.3× 20 0.8× 16 229
Weifeng He China 8 198 2.3× 51 0.7× 55 0.9× 64 1.1× 18 0.8× 13 329
Laura R. Pageon United States 8 46 0.5× 150 2.0× 57 0.9× 58 1.0× 24 1.0× 12 298
Małgorzata Bobrowicz Poland 11 123 1.4× 100 1.4× 20 0.3× 121 2.1× 16 0.7× 25 341
Lukas M. Altenburger Austria 7 125 1.4× 79 1.1× 28 0.5× 93 1.6× 21 0.9× 7 268
Hossein Saeedi Iran 10 88 1.0× 146 2.0× 29 0.5× 117 2.0× 21 0.9× 20 320
Kevin P. Labadie United States 7 81 0.9× 61 0.8× 66 1.1× 136 2.3× 32 1.3× 15 292
Diana P. Saraiva Portugal 7 94 1.1× 57 0.8× 66 1.1× 163 2.8× 23 1.0× 8 282
Xue Dong China 9 79 0.9× 71 1.0× 98 1.6× 49 0.8× 42 1.8× 18 291

Countries citing papers authored by Robert D. Schwab

Since Specialization
Citations

This map shows the geographic impact of Robert D. Schwab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Schwab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Schwab more than expected).

Fields of papers citing papers by Robert D. Schwab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Schwab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Schwab. The network helps show where Robert D. Schwab may publish in the future.

Co-authorship network of co-authors of Robert D. Schwab

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Schwab. A scholar is included among the top collaborators of Robert D. Schwab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Schwab. Robert D. Schwab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Caplan, Avrom S., Robert D. Schwab, Emily Baumrin, et al.. (2023). Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature. Blood Advances. 7(19). 5780–5783. 3 indexed citations
3.
Schwab, Robert D., et al.. (2023). Advances in cancer immunotherapies. Cell. 186(8). 1814–1814.e1. 147 indexed citations breakdown →
4.
Schwab, Robert D. & Selina M. Luger. (2023). Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?. Current Treatment Options in Oncology. 24(7). 757–769. 1 indexed citations
5.
Smith, Adam, et al.. (2020). Protamine loops DNA in multiple steps. Nucleic Acids Research. 48(11). 6108–6119. 21 indexed citations
6.
Bagley, Stephen, Robert D. Schwab, Angela N. Viaene, et al.. (2018). Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma. Journal of Neuro-Oncology. 141(2). 421–429. 15 indexed citations
7.
Fraietta, Joseph A., Robert D. Schwab, & Marcela V. Maus. (2016). Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells. Seminars in Oncology. 43(2). 291–299. 10 indexed citations
8.
Schwab, Robert D., et al.. (2015). Optimizing Tethered Particle Motion to Measure DNA Compaction by Protamine. Biophysical Journal. 108(2). 393a–393a. 1 indexed citations
9.
Posey, Avery D., et al.. (2015). 515. Targeting Hypoglycosylation with a Chimeric Antigen Receptor. Molecular Therapy. 23. S206–S206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026